Full name
STORKPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
52.10.B - Warehousing and storage of other goods
52.24.C - Cargo handling at other handling points
64.92.Z - Other forms of credit granting
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2017 | 2018 | 2019 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,7 | 0,6 | 0,2 | -71,8 |
EBITDA | 1,3 | 1,6 | 0,8 | -48,1 |
Short time liabilities | 18,3 | 13,6 | 17,2 | 26,3 |
Equity capital | 3,3 | 4 | 4,1 | 2,6 |
Operating profit (EBIT) | 1 | 1,3 | 0,5 | -59,7 |
Assets | 22,5 | 18,8 | 22,2 | 18 |
Net profit (loss) | 0,6 | 0,5 | 0,1 | -79,1 |
Cash | 0,7 | 0,3 | 0 | -88,5 |
Liabilities and provisions for liabilities | 19,2 | 14,7 | 18 | 22,3 |
Net income from sale | 41,7 | 38,9 | 34 | -12,6 |
Working assets | 19,7 | 17,5 | 21,2 | 21,2 |
Depreciation | 0,3 | 0,3 | 0,3 | 1,7 |
% | % | % | p.p. | |
Profitability of capital | 17,8 | 12,6 | 2,6 | -10 |
Equity capital to total assets | 14,6 | 21,5 | 18,7 | -2,8 |
Gross profit margin | 1,7 | 1,6 | 0,5 | -1,1 |
EBITDA Margin | 3 | 4,1 | 2,5 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 161 | 128 | 184 | 56 |
Current financial liquidity indicator | 1.0530802011489868 | 1.2537446022033691 | 1.2105542421340942 | -0,1 |
Net dept to EBITDA | 6.5684285163879395 | 5.774998664855957 | 10.28738784790039 | 4,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane